AGILIS Trademark

Trademark Overview

On Friday, January 21, 2005, a trademark application was filed for AGILIS with the United States Patent and Trademark Office. The USPTO has given the AGILIS trademark a serial number of 79012655. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, January 21, 2015. This trademark is owned by AstraZeneca AB. The AGILIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment and prevention of diabetes
agilis

General Information

Serial Number79012655
Word MarkAGILIS
Filing DateFriday, January 21, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, January 21, 2015
Registration Number3079966
Registration DateTuesday, April 11, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment and prevention of diabetes
Translation of Words in MarkThe English translation of "Agilis" is "light, easily moved".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateWednesday, March 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAtheroGenics, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS
Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events

Event DateEvent Description
Friday, August 14, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 14, 2015DEATH OF INTERNATIONAL REGISTRATION
Thursday, June 12, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, November 20, 2013TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, March 20, 2013CANCELLED SECTION 71
Thursday, January 22, 2009CHANGE OF OWNER RECEIVED FROM IB
Sunday, November 25, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 14, 2006FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 14, 2006FINAL DISPOSITION PROCESSED
Friday, November 3, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 11, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, January 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2005NOTICE OF PUBLICATION
Tuesday, November 29, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 25, 2005ASSIGNED TO LIE
Friday, November 18, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, October 26, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 26, 2005PAPER RECEIVED
Friday, October 7, 2005REFUSAL PROCESSED BY IB
Thursday, September 15, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 15, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 14, 2005NON-FINAL ACTION WRITTEN
Friday, August 26, 2005ASSIGNED TO EXAMINER
Friday, August 26, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, August 25, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

agilis prevention diabetes treatment substances preparations pharmaceutical